Our Research Journey
Morinaga Milk Industry Co., Ltd. is one of the leading dairy product companies in Japan with a century of history harnessing the nutritional properties of dairy products and functional ingredients.
Morinaga Milk is also a key global probiotics manufacturer that excels in innovative technology, offering a premium line of probiotics and functional ingredients worldwide.
1960s
Since the 1960s, Morinaga Milk has been engaged in research on the Human-Residential Bifidobacteria (HRB) to explore their beneficial functions in maintaining human health.
1969
In 1969, Morinaga Milk isolated its flagship strain Bifidobacterium longum BB536 from a healthy breast-fed infant and has ever since then discovered its multifunctional health effects.
2007
In 2007, Morinaga Milk has discovered a paraprobiotic strain, LAC-Shield™ (heat-killed L. paracasei MCC1849), and has ever since developed it with its innovative technology.
Multifunctional
Infant health
Infant use
Weight management
Human-Residential Bifidobacteria (HRB)
Morinaga Milk is some way ahead of the curve, especially when it comes to its expertise in HRB strains.
With its innovative technology, Morinaga Milk has developed a premium line of HRB probiotic strains. Each HRB strain possesses an array of benefits that meet your manufacturing needs and fulfill consumer demand.
Paraprobiotics strain
In recent years, with its innovative technology, Morinaga Milk has developed a paraprobiotic strain, LAC-Shield™ (heat-killed L. paracasei MCC1849) that specifically addresses the increased interest in immune health.
LAC-Shield is a patented clinically proven heat-killed strain of beneficial lactic acid bacteria that possess excellent immune-enhancing activity.
LAC-Shield was named for its unique immunological function serving as a "shield" to protect the human body against invading enemies.
Your Innovative Probiotics Solution
With a rigor safety and efficacy profile, Morinaga Milk’s HRB probiotics and its unique paraprobiotic strain deliver your desired results in NPD.
Click to expand
Multifunctional
Bifidobacterium longum BB536 is one of the most well-established, clinically effective probiotic strains that have a proven track record of safety and clinical efficacy in improving gastrointestinal, immunological, and infectious conditions, as demonstrated in > 210 scientific studies (as of April 2021).
Click to expand
Infant health
Bifidobacterium breve M-16V is one of the best-studied clinically effective probiotic strains that exert positive effects, particularly in infants, to support healthy growth and promote well-being, as demonstrated in >100 scientific studies (as of April 2021).
Click to expand
Infant use
Bifidobacterium infantis M-63 is unique among gut bacteria in its immense capacity to utilize human milk oligosaccharide (HMOs), the component that is highly abundant in human breast milk. HMOs offer no direct nutritive value for infants, but they function in shaping a better infant gut microbiota with life-long impacts. M-63 possesses superior potential to colonize and adapt to the intestinal environment of humans, especially infants.
Click to expand
Weight management
Bifidobacterium breve B-3 is a unique probiotic strain developed by focusing on the relationship between gut microbiota and metabolic syndrome. B-3 possesses an attractive effect in maintaining healthy body weight and ultimately improving one's lifestyle.
Click to expand
Immune health
Backed with several clinical studies, LAC-Shield™ serves as a unique
functional ingredient in the immune health space. LAC-Shield™ does not pose stability issues of traditional probiotics,
as it is an inactivated probiotic strain. Manufacturers can meet consumer demand for a variety of foods and beverages by innovating with LAC-Shield™.
back to top
Multifunctional
Bifidobacterium longum BB536 is one of the most well-established, clinically effective probiotic strains that have a proven track record of safety and clinical efficacy in improving gastrointestinal, immunological, and infectious conditions, as demonstrated in > 210 scientific studies (as of April 2021).
Infant health
Bifidobacterium breve M-16V is one of the best-studied clinically effective probiotic strains that exert positive effects, particularly in infants, to support healthy growth and promote well-being, as demonstrated in >100 scientific studies (as of April 2021).
Weight management
Bifidobacterium breve B-3 is a unique probiotic strain developed by focusing on the relationship between gut microbiota and metabolic syndrome. B-3 possesses an attractive effect in maintaining healthy body weight and ultimately improving one's lifestyle.
Infant use
Bifidobacterium infantis M-63 is unique among gut bacteria in its immense capacity to utilize human milk oligosaccharide (HMOs), the component that is highly abundant in human breast milk. HMOs offer no direct nutritive value for infants, but they function in shaping a better infant gut microbiota with life-long impacts. M-63 possesses superior potential to colonize and adapt to the intestinal environment of humans, especially infants.
Immune health
Backed with several clinical studies, LAC-Shield™ serves as a unique
functional ingredient in the immune health space. LAC-Shield™ does not pose stability issues of traditional probiotics,
as it is an inactivated probiotic strain. Manufacturers can meet consumer demand for a variety of foods and beverages by innovating with LAC-Shield™.